Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1953 4
1956 2
1960 1
1963 2
1967 1
1971 3
1972 2
1973 1
1974 3
1975 2
1977 2
1978 1
1979 3
1980 1
1982 1
1983 1
1986 2
1988 1
1989 1
1990 10
1991 7
1992 4
1993 9
1994 7
1995 2
1996 2
1997 4
1998 9
1999 28
2000 13
2001 21
2002 24
2003 41
2004 46
2005 52
2006 62
2007 32
2008 46
2009 38
2010 52
2011 66
2012 66
2013 90
2014 105
2015 153
2016 159
2017 119
2018 137
2019 156
2020 164
2021 167
2022 173
2023 165
2024 61

Text availability

Article attribute

Article type

Publication date

Search Results

2,041 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Haladin
Page 1
AI-powered therapeutic target discovery.
Pun FW, Ozerov IV, Zhavoronkov A. Pun FW, et al. Trends Pharmacol Sci. 2023 Sep;44(9):561-572. doi: 10.1016/j.tips.2023.06.010. Epub 2023 Jul 19. Trends Pharmacol Sci. 2023. PMID: 37479540 Free article. Review.
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies.
Lachowiez CA, Loghavi S, Zeng Z, Tanaka T, Kim YJ, Uryu H, Turkalj S, Jakobsen NA, Luskin MR, Duose DY, Tidwell RSS, Short NJ, Borthakur G, Kadia TM, Masarova L, Tippett GD, Bose P, Jabbour EJ, Ravandi F, Daver NG, Garcia-Manero G, Kantarjian H, Garcia JS, Vyas P, Takahashi K, Konopleva M, DiNardo CD. Lachowiez CA, et al. Blood Cancer Discov. 2023 Jul 5;4(4):276-293. doi: 10.1158/2643-3230.BCD-22-0205. Blood Cancer Discov. 2023. PMID: 37102976 Free PMC article. Clinical Trial.
The safety and efficacy of combining the isocitrate dehydrogenase-1 (IDH1) inhibitor ivosidenib (IVO) with the BCL2 inhibitor venetoclax (VEN; IVO + VEN) azacitidine (AZA; IVO + VEN + AZA) were evaluated in four cohorts of patients with IDH1-mutated myeloid m …
The safety and efficacy of combining the isocitrate dehydrogenase-1 (IDH1) inhibitor ivosidenib (IVO) with the BCL2 inhibitor venetoc …
New associate editor prof. Dr. Ivo Meinhold-Heerlein.
Meinhold-Heerlein I. Meinhold-Heerlein I. Arch Gynecol Obstet. 2015 Feb;291(2):237. doi: 10.1007/s00404-014-3607-8. Arch Gynecol Obstet. 2015. PMID: 25542220 No abstract available.
Ivo Pitanguy.
Collucci C. Collucci C. BMJ. 2016 Aug 11;354:i4415. doi: 10.1136/bmj.i4415. BMJ. 2016. PMID: 27515065 No abstract available.
Ivo Abrahao Nesralla (1938-2020).
Kalil RAK. Kalil RAK. Braz J Cardiovasc Surg. 2021 Apr 1;36(2):272-274. doi: 10.21470/1678-9741-2021-0951. Braz J Cardiovasc Surg. 2021. PMID: 34048206 Free PMC article. No abstract available.
Reply.
Brosens I, Benagiano G. Brosens I, et al. Am J Obstet Gynecol. 2020 Jul;223(1):137. doi: 10.1016/j.ajog.2020.02.014. Epub 2020 Feb 20. Am J Obstet Gynecol. 2020. PMID: 32088193 No abstract available.
2,041 results